Hilde Erdal's picture
Studio 1 fotografene

Hilde Erdal

PhD Candidate, Project manager for SUKK-P prospective study of hyperemesis gravidarum treatment
  • E-mailHilde.Erdal@uib.no
  • Phone+47 55 58 85 95
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study. International Journal of Clinical Practice.
  • Show author(s) (2022). Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service. BMC Pregnancy and Childbirth.
  • Show author(s) (2022). Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019. BMC Pregnancy and Childbirth. 13 pages.
  • Show author(s) (2020). Perception of prescribing factors and purchase statistics of non-steroidal anti-inflammatory drugs in an orthopedic clinic. BMC Research Notes. 1-6.
  • Show author(s) (2014). Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study. BMC Complementary and Alternative Medicine.
  • Show author(s) (2011). Prescriptions from general practitioners and in hospital physicians requiring pharmacists' interventions. Pharmacoepidemiology and Drug Safety. 50-56.
  • Show author(s) (2019). Experience with the internet-based service SafeMummyMedicine: A Norwegian medicines information service for pregnant and breastfeeding women.
  • Show author(s) (2012). Hvilke spørsmål får RELIS om alternativ medisin – og hvordan svarer vi?

More information in national current research information system (CRIStin)